期刊文献+

卵巢恶性肿瘤的雌孕激素受体研究 被引量:2

THE STUDY OF ESTROGEN AND PROGESTERONE RECEPTORS IN OVARIAN CANCER
下载PDF
导出
摘要 用葡聚糖-活性碳吸附法(DCC法)对87例卵巢恶性肿瘤的雌激素受体(ER)及孕激素受体(PR)进行了测定。ER、PR的阳性率分别为50.6%和58.6%。在不同组织类型中,宫内膜样癌的ER与PR高于其它癌。PR与临床分期呈负相关。多因素分析显示ER、PR均阳性者预后好。ER与PR的测定有助于了解病人预后,对卵巢癌的内分泌治疗有一定指导作用。 evels of estrogen receptor(ER) and progesterone receptor(PR)in ovarian cancer tissues were examined withregard to their clinical significance. Hormone receptor content was determined with the DCC method, receptor val-ues higher than 10 fmol/mg protein were considered positive. Of 87 samples from patients with ovarian concer,50.6%were ER-positive, 58.6%PR-positive; 34. 5%were ER-positive,PR-positive(ER+PR+ ),and 25.3%ER-negative, PR-negative(ER-pR-).There was a positive correlation between ER and PR,P<0. 01. The PRlevel in stage I ovarian cancer was higher than in advanced diseases(FIGO stage Ⅲ and Ⅳ ),P<0 05,and the ERand pR level in endometrioid histology was higher than those in the other histologic types,P<0.05.There was nocorrelation between receptor status and patient’s age,menopausal status or tumor grade of epithelial ovarian can-cer. A Cox proportional hazards regression model identified hormone receptor status as an independent prognosticfactor for survival,both ER and PR positive tumors had a better prognosis,P<0.01.We suggest that ER and PRbe useful in predicting the prognosis of patients with ovarian cancer, and we expect that the determination of ERand PR will play a role in the hormonal therapy of ovarian cancer.
出处 《北京医科大学学报》 CSCD 1995年第5期371-373,共3页 Journal of Peking University(Health Sciences)
关键词 卵巢肿瘤 雌激素 孕激素 受体 Headings Receptors,estrogen/anal Receptors,progesterone/anal Ovarian neoplasms
  • 相关文献

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部